Publications
Most Food Labeling Class Actions Remain Stayed While FDA Process Runs ‘Natural’ Course
October 23, 2017
Consumer class actions over the use of the term ‘‘natural’’ on product labels should be stayed in deference to the Food and Drug Administration’s ongoing consideration of regulatory action, Sidley lawyers Amy Lally and Amanda Farfel say. The large number of comments received by the FDA on the topic reflects the complexity of the issues and the need for expert guidance from the agency the authors say.
Capabilities
Suggested News & Insights
Sidley Clinches Victory in HEC AD/CVD InvestigationsJanuary 30, 2026Sidley Represents Glenfarne as Principal Project Counsel on Alaska LNGJanuary 29, 2026Sidley Advises Marathon Asset Management on its up to US$1.6 Billion Sale to CVCJanuary 26, 2026Sidley Advises on Market-Defining Cross-Border India Matters in 2025January 12, 2026New U.S. Executive Order Targets Stock Buybacks, Dividends, and Executive Compensation for Underperforming Defense ContractorsJanuary 9, 2026Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
